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Abstract
While initiation of cannabis use is around 40% heritable, not much is known about the underlying
genetic etiology. Here, we meta-analysed two genome-wide association studies of initiation of
cannabis use with (>10,000 individuals). None of the genetic variants reached genome-wide
significance. We also performed a gene-based association test, which also revealed no significant
effects of individual genes. Finally, we estimated that only approximately 6.0% of the variation in
cannabis initiation is due to common genetic variants. Future genetic studies using larger sample
sizes and different methodologies (including sequencing) might provide more insight in the
complex genetic etiology of cannabis use.
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Cannabis is the most widely used illicit drug worldwide, and numerous population based
family and twin studies indicate that risk of cannabis use runs in families. A recent meta-
analysis of existing twin studies reported heritability estimates of 45% for males and 39%
for females for cannabis use initiation (Verweij, Zietsch, Lynskey, et al., 2010). Not much is
known about the genetic variants and biological mechanisms underlying this heritability.
The few linkage studies that examined cannabis use phenotypes reported non-overlapping
linkage peaks that did not meet genome-wide significance (see Agrawal and Lynskey,
2009). Candidate gene association studies for cannabis use have mainly focussed on genes
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known to be involved in the endogenous cannabinoid system: the cannabinoid receptor 1
gene (CNR1) and the fatty acid amide hydrolase gene (FAAH). But again, while some
nominally significant associations were reported, others were unable to replicate these (see
Agrawal and Lynskey, 2009). A recent large scale study testing for association of these two
and eight other candidate genes with lifetime frequency of cannabis use did not support
association with any of the genes (Verweij, Zietsch, Liu, et al., 2011; NB: this study used the
same Australian subsample as used in the present study). The lack of replication may point
to potential publication bias and false-positive findings in candidate gene association studies
and also highlights the limited understanding of the neurobiology of cannabis use. Other,
hypothesis-free, approaches are therefore needed to further unravel the genetic etiology of
cannabis use.
Recently, Agrawal et al. (2011) performed the first genome-wide association study for
cannabis use phenotypes, using a sample of 708 cannabis-dependent cases and 2,346
controls. They did not identify any genetic variants significantly associated with cannabis
dependence, potentially because of a lack of statistical power. The present study has two
components. First, we meta-analysed results from two genome-wide association analyses of
initiation of cannabis use (ever versus never) in order to identify genetic variants underlying
cannabis use. With a combined sample size of over 10,000 individuals (from 4,622
independent families) and a substantially higher number of cases, this study provided more
power to identify genetic variants of small effect size than the study by Agrawal et al.
(2011). Secondly, we used a recently developed method utilising genome-wide SNP data to
estimate the overall percentage of variance in initiation of cannabis use that is due to
common genetic variants, which will provide insight into the genetic etiology underlying
cannabis use.
Data used in this study come from Australian and UK (TwinsUK, http://www.twinsuk.ac.uk;
Spector and Williams, 2006) twin registries (see Table 1 for sample details). As part of
larger questionnaires, individuals were asked whether they had ever used cannabis. Table 1
shows the prevalence of cannabis use initiation for individuals included in the present study.
It should be noted that the prevalence is substantially higher in the Australian sample.
Higher levels of cannabis use have generally been reported in Australia than in the UK
(UNODC, 2010), but the difference may be larger due to age differences between the two
samples and because a subset of the Australian sample has been ascertained for familial
alcohol and nicotine use.
Genotype data were obtained using different Illumina SNP platforms (317K,
HumanCNV370-Quadv3, HumanCNV370v1, and Human610-Quad). Standard quality
control procedures were applied as outlined previously (Medland, Nyholt, Painter, et al.,
2009), including checks for ancestry outliers, Hardy Weinberg Equilibrium, Mendelian
errors, call rate, and minor allele frequency. Subsequently, both datasets were imputed
separately using MACH (Li, Willer, Ding, et al., 2010) using reference data from the
European HapMap I + II samples, (Release 22 Build 36). Only SNPs with an imputation
quality score (r2) greater than 0.3 were retained, and SNPs were filtered on allele frequency.
In total, ~2,4 million SNPs were available for the association analyses.
For each sample separately, the dosage score at each SNP was tested for association with
cannabis use initiation using the family-based association test implemented in Merlin-offline
(Chen and Abecasis, 2007), correcting for sex, age, age2, and sex*age effects. We performed
a total test of association which employs a linear regression method while explicitly
correcting for the relatedness between family members (including MZ twins) within the
variance/covariance model. The strongest associations were verified using the Generalized
Disequilibrium Test (GDT, Chen, Manichaikul, and Rich, 2009) which is specifically
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designed for use with dichotomous data. However, unlike Merlin-offline, which can analyse
dosage data, GDT can only be used with hard-call genotypes, which are less informative
than dosage data thus resulting in a less powerful test. A meta-analysis of the association
results from both studies was conducted in METAL (Abecasis, 2009) using the effect sizes
of the SNPs along with their standard errors. Next, we conducted a gene-based test
(VEGAS, Liu, McRae, Nyholt, et al., 2010) in order to determine if particular genes harbour
an excess of associated variants. This test summarises evidence for association on a per gene
basis by considering the p-value of all SNPs within the gene, while accounting for linkage
disequilibrium and number of SNPs in the gene.
Results from the meta-analysis are summarised in Figure 1 (Manhattan plot), Supplementary
Figure 1 (Q-Q plot), and Supplementary Table 1 (strongest associations; note that the results
were similar with Merlin-offline and GDT), and the strongest gene-based associations are
shown in Supplementary Table 2. We did not identify any SNP or gene that was
significantly associated with cannabis use initiation, after correcting for multiple testing. An
approximate power calculation (Purcell, Cherny, and Sham, 2003) indicates the combined
samples provided 65% and 98% power to detect a genetic variant (with a minor allele
frequency of 0.25) with a relative risk of 1.15 and 1.2, respectively. This indicates that
individual common genetic variants of this size or greater do not contribute to individual
differences in initiation of cannabis use. The power calculation shows that our sample is
underpowered to detect common genetic variants of smaller effect sizes, indicating the need
for larger sample sizes to enable the detection of these variants.
We then estimated the proportion of variance in initiation of cannabis use that could be
explained by the aggregate effect of all SNPs using GCTA (Yang, Lee, Goddard, et al.,
2011). This estimate is obtained by correlating the genetic similarity (i.e. the identity by
state at the SNP level) between individuals (relatedness < 0.025) with their phenotypic
similarity. The methodology is explained in more detail in the Supplementary material. We
estimated that only 6.0% (SE=10.2, p=0.28) of the variance in cannabis use initiation is due
to the aggregated effect of common variants. The relatively large standard error indicates
that this estimate is somewhat imprecise, mostly due to the limited power of the sample
(N=4612 unrelated individuals), but also by the measurement of the phenotype (binary, as
opposed to continuous) and potentially by the heterogeneity of the phenotype between the
two samples.
This SNP-based heritability estimate is substantially lower than the heritability estimate of
~40% obtained from twin studies (Verweij, et al., 2010). The discrepancy between twin and
SNP-based heritability estimates is larger than for some other phenotypes, such as height
and intelligence (Davies, Tenesa, Payton, et al., 2011; Yang, Benyamin, McEvoy, et al.,
2010), but similar to for example personality, where the SNP-based estimates for various
personality traits are between 4 and 12%, while the twin and family-based heritability
estimates are between 30 and 60% (Verweij, Yang, Lahti, et al., 2012; Vinkhuyzen,
Pedersen, Yang, et al., 2012). Note that heritability estimates from twin studies include the
effects of all causal genetic variants, while the heritability estimated using GCTA includes
only the effects of variants that are in linkage disequilibrium with the SNPs included in the
analyses. These SNPs do not capture all genetic variants, especially not rare variants or
variants with low minor allele frequencies. Although the SNP-based heritability estimate is
somewhat imprecise due to limited power, the result raises the possibility that the role of
common genetic variants in the heritability of initiation of cannabis use is low, which could
help to explain why we were unable to find any genetic association. It may also suggest that
non-additive genetic effects (dominance and/or epistasis), interactions with the environment,
and/or rare mutations also play a role. Alternatively, twin studies may have overestimated
the relative contribution of genetic influences (see Vinkhuyzen, et al., 2012). As with other
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complex traits, future genetic studies using larger sample sizes and different methodologies
(including sequencing) might provide more insight in the complex genetic etiology of
cannabis use.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Results of the genome-wide association analyses for lifetime cannabis use. The x-axis shows
the chromosome numbers and the y-axis the significance of the association signals (i.e.
−log10(P) value).
Verweij et al. Page 6
Addict Biol. Author manuscript; available in PMC 2014 September 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Verweij et al. Page 7
Ta
bl
e 
1
Sa
m
pl
e 
de
sc
rip
tiv
es
.
A
us
tr
al
ia
(N
=2
,53
8 i
nd
ep
en
de
nt
 fa
mi
lie
s)
U
K
(N
=2
08
4 i
nd
ep
en
de
nt
 fa
mi
lie
s)
M
al
es
Fe
m
al
es
To
ta
l
M
al
es
Fe
m
al
es
To
ta
l
Sa
m
pl
e 
Si
ze
32
92
38
83
71
75
21
6
27
00
29
16
A
ge
 (M
±S
D)
45
.2
 ±
 1
0.
8
44
.5
 ±
 1
1.
1
44
.8
 ±
 1
1.
0
58
.7
 ±
 1
3.
5
58
.7
 ±
 1
2.
2
58
.7
 ±
 1
2.
3
Pe
rc
en
ta
ge
 o
f i
nd
iv
id
ua
ls
th
at
 h
av
e 
us
ed
 c
an
na
bi
s
58
.4
%
47
.4
%
52
.4
%
18
.5
%
11
.3
%
11
.8
%
N
ot
e 
th
at
 th
e 
A
us
tra
lia
n 
sa
m
pl
e 
in
cl
ud
es
 4
03
 a
nd
 th
e 
U
K
 sa
m
pl
e 
22
4 
id
en
tic
al
 tw
in
 p
ai
rs
Addict Biol. Author manuscript; available in PMC 2014 September 01.
